Authors:
BECKER M
PORT RE
ZABEL HJ
ZELLER WJ
BACHERT P
Citation: M. Becker et al., MONITORING LOCAL DISPOSITION KINETICS OF CARBOPLATIN IN-VIVO AFTER SUBCUTANEOUS INJECTION IN RATS BY MEANS OF PT-195 NMR, Journal of magnetic resonance [1997], 133(1), 1998, pp. 115-122
Authors:
HABERKORN U
KREMS B
GERLACH L
BACHERT P
MORR I
WIESSLER M
VANKAICK G
Citation: U. Haberkorn et al., ASSESSMENT OF GLUCOSYLIFOSFAMIDE MUSTARD BIODISTRIBUTION IN RATS WITHPROSTATE ADENOCARCINOMAS BY MEANS OF IN-VIVO P-31 NMR AND IN-VITRO UPTAKE EXPERIMENTS, Magnetic resonance in medicine, 39(5), 1998, pp. 754-761
Authors:
SCHULZE A
MAYATEPEK E
BACHERT P
MARESCAU B
DEDEYN PP
RATING D
Citation: A. Schulze et al., THERAPEUTIC TRIAL OF ARGININE RESTRICTION IN CREATINE DEFICIENCY SYNDROME, European journal of pediatrics, 157(7), 1998, pp. 606-607
Authors:
WELLER E
BACHERT P
MEINCK HM
FRIEDMANN B
BARTSCH P
MAIRBAURL H
Citation: E. Weller et al., LACK OF EFFECT OF ORAL MG-SUPPLEMENTATION ON MG IN SERUM, BLOOD-CELLS, AND CALF MUSCLE, Medicine and science in sports and exercise, 30(11), 1998, pp. 1584-1591
Authors:
SCHULZE A
MAYATEPEK E
LANGHANS CD
BACHERT P
RUITENBEEK W
RATING D
Citation: A. Schulze et al., IN-VIVO METHODS USEFUL FOR THERAPY MONITORING IN LACTIC-ACIDOSIS, Journal of inherited metabolic disease, 21(6), 1998, pp. 691-692
Authors:
SCHULZE A
MAYATEPEK E
FRANK S
MARESCAU B
DEDEYN PP
BACHERT P
Citation: A. Schulze et al., DISTURBED METABOLISM OF GUANIDINO COMPOUNDS CHARACTERIZED BY ELEVATEDEXCRETION OF BETA-GUANIDINOPROPIONIC ACID AND GAMMA-GUANIDINOBUTYRIC ACID - AN EFFECT OF VIGABATRIN TREATMENT, Journal of inherited metabolic disease, 21(3), 1998, pp. 268-271
Authors:
SCHLEMMER H
BECKER M
BACHERT P
DIETZ A
VANSELOW B
RUDAT V
Citation: H. Schlemmer et al., DOES IRRADIATION AFFECT THE INTRATUMORAL PHARMACOKINETICS OF 5-FU - IN-VIVO F-19 MR SPECTROSCOPY STUDY IN PATIENTS WITH HEAD AND NECK CARCINOMAS, Radiology, 209P, 1998, pp. 1520-1520
Authors:
SCHLEMMER HP
DIETZ A
BECKER M
WOLLENSACK P
BACHERT P
RUDAT V
VANSELOW B
KNOPP M
WANNENMACHER M
WEIDAUER H
VANKAICK G
Citation: Hp. Schlemmer et al., MONITORING OF 5-FU PHARMACOKINETICS IN CERVICAL LYMPH-NODE METASTASESFROM HEAD AND NECK CARCINOMAS BY MEANS OF IN-VIVO 19F MR SPECTROSCOPY, British Journal of Cancer, 77, 1998, pp. 125-125
Citation: P. Bachert, KINETICS OF HETERONUCLEAR CROSS-RELAXATION IN DIPOLAR COUPLED-SPIN SYSTEMS - APPLICATIONS TO IN-VIVO MEASUREMENTS, Concepts in magnetic resonance, 9(4), 1997, pp. 227-245
Authors:
SCHULZE A
HESS T
WEVERS R
MAYATEPEK E
BACHERT P
MARESCAU B
KNOPP MV
DEDEYN PP
BREMER HJ
RATING D
Citation: A. Schulze et al., CREATINE DEFICIENCY SYNDROME CAUSED BY GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY - DIAGNOSTIC-TOOLS FOR A NEW INBORN ERROR OF METABOLISM, The Journal of pediatrics, 131(4), 1997, pp. 626-631
Authors:
BACHERT P
SCHAD LR
BOCK M
KNOPP MV
EBERT M
GROSSMANN T
HEIL W
HOFMANN D
SURKAU R
OTTEN EW
Citation: P. Bachert et al., NUCLEAR-MAGNETIC-RESONANCE IMAGING OF AIRWAYS IN HUMANS WITH USE OF HYPERPOLARIZED HE-3, Magnetic resonance in medicine, 36(2), 1996, pp. 192-196
Authors:
DIMITRAKOPOULOUSTRAUSS A
STRAUSS LG
KREMS B
BACHERT P
HOHENBERGER P
SCHLAG P
SEMMLER W
OBERDORFER F
HABERKORN U
VANKAICK G
Citation: A. Dimitrakopouloustrauss et al., STUDIES OF FLUOROURACIL (FU) PHARMACOKINETICS USING POSITRON EMISSIONTOMOGRAPHY (PET) AND MAGNETIC-RESONANCE SPECTROSCOPY (MRS), The Journal of nuclear medicine, 37(5), 1996, pp. 1151-1151
Authors:
HABERKORN U
KREMS B
GERLACH L
MORR I
BACHERT P
STRAUSS LG
DIMITRAKOPOULOUSTRAUSS A
WIESSLER M
VANKAICK G
Citation: U. Haberkorn et al., ASSESSMENT OF GLUCOSYLIFOSFAMIDE BIODISTRIBUTION IN RATS WITH PROSTATE ADENOCARCINOMA, The Journal of nuclear medicine, 37(5), 1996, pp. 1183-1183
Authors:
BACHERT P
SCHAD LR
BOCK M
KNOPP MV
EBERT M
GROSSMANN T
HEIL W
HOFMANN D
OTTEN EW
SURKAU R
VANKAICK G
LORENZ WJ
Citation: P. Bachert et al., HYPERPOLARIZED HE-3 NUCLEAR-MAGNETIC-RESONANCE IMAGING OF HUMAN LUNGS, The Journal of nuclear medicine, 37(5), 1996, pp. 1320-1320
Citation: B. Krems et al., F-19-(H-1) NUCLEAR OVERHAUSER EFFECT AND PROTON DECOUPLING OF 5-FLUOROURACIL AND ALPHA-FLUORO-BETA-ALANINE, Journal of magnetic resonance. Series B, 108(2), 1995, pp. 155-164
Authors:
BRIX G
BELLEMANN ME
HABERKORN U
GERLACH L
BACHERT P
LORENZ WJ
Citation: G. Brix et al., MAPPING THE BIODISTRIBUTION AND CATABOLISM OF 5-FLUOROURACIL IN TUMOR-BEARING RATS BY CHEMICAL-SHIFT SELECTIVE F-19 MR-IMAGING, Magnetic resonance in medicine, 34(3), 1995, pp. 302-307
Authors:
SIJENS PE
KNOPP MV
BRUNETTI A
WICKLOW K
ALFANO B
BACHERT P
SANDERS JA
STILLMAN AE
KETT H
SAUTER R
OUDKERK M
Citation: Pe. Sijens et al., H-1 MR SPECTROSCOPY IN PATIENTS WITH METASTATIC BRAIN-TUMORS - A MULTICENTER STUDY, Magnetic resonance in medicine, 33(6), 1995, pp. 818-826
Authors:
HESS T
MUELLER C
BACHERT P
DEBUS J
KNOPP MV
ESSIG M
Citation: T. Hess et al., MONITORING RESULTS OF RADIATION-THERAPY FOR LOW-GRADE ASTROCYTOMA WITH H-1 MR SPECTROSCOPY, Radiology, 197, 1995, pp. 193-193
Authors:
WEISSER G
BACHERT P
KNOPP MV
JUNKERMANN HJ
HESS T
VANKAICK G
Citation: G. Weisser et al., EVALUATION OF CHANGES IN BREAST-CANCER TISSUE AND NORMAL BREAST-TISSUE DURING NEOADJUVANT CHEMOTHERAPY BY MEANS OF PROTON-DECOUPLED P-31 MRSPECTROSCOPY, Radiology, 197, 1995, pp. 289-289
Authors:
SCHLEMMER HP
BACHERT P
SEMMLER W
HOHENBERGER P
SCHLAG P
LORENZ WJ
VANKAICK G
Citation: Hp. Schlemmer et al., DRUG-MONITORING OF 5-FLUOROURACIL - IN-VIVO F-19 NMR-STUDY DURING 5-FU CHEMOTHERAPY IN PATIENTS WITH METASTASES OF COLORECTAL ADENOCARCINOMA, Magnetic resonance imaging, 12(3), 1994, pp. 497-511
Citation: Re. Port et al., PHARMACOKINETIC ANALYSIS OF SPARSE IN-VIVO NMR-SPECTROSCOPY DATA USING RELATIVE PARAMETERS AND THE POPULATION APPROACH, European Journal of Clinical Pharmacology, 47(2), 1994, pp. 187-193